205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.16%
Revenue growth at 50-75% of LSCC's 5.24%. Martin Whitman would worry about competitiveness or product relevance.
7.64%
Gross profit growth 1.25-1.5x LSCC's 6.70%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
-97.12%
Negative EBIT growth while LSCC is at 12.12%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-97.12%
Negative operating income growth while LSCC is at 12.12%. Joel Greenblatt would press for urgent turnaround measures.
0.75%
Net income growth under 50% of LSCC's 9.80%. Michael Burry would suspect the firm is falling well behind a key competitor.
-7.69%
Negative EPS growth while LSCC is at 338.29%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
26.80%
Share change of 26.80% while LSCC is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-7.31%
Reduced diluted shares while LSCC is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-21.13%
Dividend reduction while LSCC stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
19.36%
OCF growth under 50% of LSCC's 100.00%. Michael Burry might suspect questionable revenue recognition or rising costs.
62.50%
FCF growth under 50% of LSCC's 214.29%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
77.23%
10Y revenue/share CAGR under 50% of LSCC's 314.31%. Michael Burry would suspect a lasting competitive disadvantage.
35.62%
5Y revenue/share CAGR under 50% of LSCC's 314.31%. Michael Burry would suspect a significant competitive gap or product weakness.
28.40%
3Y revenue/share CAGR under 50% of LSCC's 78.09%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
627.81%
3Y OCF/share CAGR above 1.5x LSCC's 189.43%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
954.25%
10Y net income/share CAGR of 954.25% while LSCC is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
40.07%
Net income/share CAGR of 40.07% while LSCC is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
314.28%
3Y net income/share CAGR above 1.5x LSCC's 142.98%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.17%
Negative 3Y equity/share growth while LSCC is at 80.36%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
3.56%
Dividend/share CAGR of 3.56% while LSCC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-41.28%
Negative near-term dividend growth while LSCC invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
10.84%
AR growth well above LSCC's 9.35%. Michael Burry fears inflated revenue or higher default risk in the near future.
2.55%
We show growth while LSCC is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
7.36%
Asset growth above 1.5x LSCC's 3.69%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-15.41%
We have a declining book value while LSCC shows 5.84%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
1.99%
Debt growth of 1.99% while LSCC is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
8.63%
We expand SG&A while LSCC cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.